The Missing Ingredient for Big Tech's $3T Recipe?
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
| Open | 47.21 | Prev Close | 47.63 |
| High | 47.26 | Low | 46.69 |
| Volume | 7,024,133 | Volume (Avg) | 15,599 |
| 52 Week High | 61.84 | 52 Week Low | 37.72 |
| Market Cap | 95.5B | PE Ratio | 17.62 |
General
| Name | Bristol-Myers Squibb Co |
| Ticker | BMY |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 34,100 |
About Bristol-Myers Squibb Co
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company's products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthritis; and Sprycel to treat patients with Philadelphia chromosome-positive chronic myeloid leukemia. It also provides Yervoy for the treatment of patients with unresectable or metastatic melanoma; Empliciti for the treatment of relapsed/refractory multiple myeloma; Abecma for the treatment of patients with relapsed or refractory multiple myeloma; Reblozyl to treat anemia; Opdualag for the treatment of unresectable or metastatic melanoma; and Zeposia to treat relapsing forms of multiple sclerosis. In addition, the company offers Breyanzi for the treatment of patients with relapsed or refractory large B-cell lymphoma; Cobenfy to treat schizophrenia in adults; Krazati for the treatment of adult patients with KRASG12C-mutated locally advanced or metastatic non-small cell lung cancer (NSCLC); Camzyos to treat symptomatic obstructive HCM to improve functional capacity and symptom; Sotyktu for the treatment of moderate-to-severe plaque psoriasis; Augtyro for the treatment of locally advanced or metastatic ROS1-positive NSCLC; Revlimid, an oral immunomodulatory drug to treat multiple myeloma; and Abraxane for the treatment of breast cancer, NSCLC and pancreatic cancer. It sells products to wholesalers, distributors, pharmacies, retailers, hospitals, clinics, and government agencies. The company was formerly known as Bristol-Myers Company. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in Princeton, New Jersey.
Highlights
| Analyst Target | 55.95 |
| Market Cap | 95,486,000,000 |
| PE Ratio | 17.62 |
| PEG Ratio | 2.26 |
| EBITDA | 19,174,000,640 |
Valuation
| Trailing PE | 17.51 |
| Forward PE | 6.97 |
| Price/Sales (Trailing 12 Mt.) | 2.00 |
| Price/Book (Most Recent Quarter) | 5.49 |
Technicals
| Beta | 0.37 |
| 52 Week High | 61.84 |
| 52 Week Low | 37.72 |
| 50 Day Average | -1.90% |
| 200 Day Average | -13.19% |
Dividend
Bristol-Myers Squibb Co pays out a dividend of $2.48 per share, with a dividend yield of 5.29%.
BMY's next dividend payment will be made to shareholders on August 1, 2025.
They pay out 0.00% of their earnings out as a dividend.
Recent Dividends
| Dec 31, 1969 | $0.62 |
| May 1, 2025 | $0.62 |
| Feb 3, 2025 | $0.62 |
| Nov 1, 2024 | $0.60 |
| Aug 1, 2024 | $0.60 |
| May 1, 2024 | $0.60 |
| Feb 1, 2024 | $0.60 |
| Nov 1, 2023 | $0.57 |
| Aug 1, 2023 | $0.57 |
A judge resisted Trump’s order on gender identity. The EEOC just fired her
The federal agency charged with protecting workers’ civil rights has terminated a New York administrative judge who , including President Donald Trump’s executive order decreeing male and female as .
This Stock Just Popped 30% In 5 Days — Now Expert Says It 'Looks Potentially Explosive'
Experts have been betting on the growth prospects of Oscar Health, as it surged by 16.51% on Wednesday and 32.56% in the last five days.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
Mystery Seller Behind $105 Million Plot Next to Jeff Bezos Estate Finally Revealed
A plot of land neighboring Jeff Bezos' property in Miami was sold for a staggering $105 million. The undeveloped lot was sold by German investor Mikhail Peleg.
Bernie Sanders Shares First Thing He Would Do As President — And It Could Be A Jab At Elon Musk
Bernie Sanders lost the 2016 and 2020 presidential races. In a recent interview, Sanders shared what he would do first if he were president.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
Trump Says Israel Ready For 60 Day Ceasefire In Gaza, Hopes Hamas Takes The Deal Because It Won't 'Get Better'
Trump proposed 60-day ceasefire in Gaza, which Israel has agreed to. Qatar and Egypt will deliver the proposal to Hamas. Trump meets Netanyahu next week.
Vistra's Rally Explained: Where Is The Stock Headed Next
Vistra stock's bullish structure remains intact. Here's a breakdown of what triggered the move and where VST is likely headed next.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Kevin O'Leary Once Said That Business School Graduates Know Nothing Until The Real World Smacks Them, Something He Learned The Hard Way— Now He Can Spot A Winner In 15 Minutes Flat
Kevin O'Leary says real-world experience—not business school—taught him to trust his intuition, which now allows him to spot winning entrepreneurs in just 15 minutes with near-perfect accuracy.
How to build a portfolio you don’t have to babysit
If you’re a do-it-yourself investor aiming to build a “no babysitter required” portfolio, here are the key steps to take.
How High Will Gold Surge? - Ad
Gold is on fire - hitting $3,500 and outpacing stocks, tech, even Bitcoin. Analyst Sean Brodrick called it, and now he's forecasting a surge to $6,900. But the biggest opportunity isn't bullion. It's a little-known investment that's returned up to 1,000x more than physical gold.
Senate Republicans move to slash CFPB funding by half, risking hundreds of job cuts
NEW YORK (AP) — Senate Republicans have moved to cut the funding of the Consumer Financial Protection Bureau by roughly half, as part of President Trump’s “Big Beautiful Bill,” which is likely to lead to hundreds of job cuts at the nation’s financial watchdog agency.
German court suspends diesel scandal trial of former Volkswagen CEO Winterkorn
FRANKFURT, Germany (AP) — A German court has suspended proceedings of former Volkswagen CEO Martin Winterkorn, who has been charged with fraud and market manipulation in connection with the automaker's use of rigged software that let millions of diesel-engine cars cheat on emissions tests.
FDA Submission Expected This Summer - Invest Before It Happens - Ad
This company is making heart disease easier to detect with AI. Their tech has officially been designated a "Breakthrough" by the FDA. You now have an opportunity to get in at a potential inflection point.
Dalai Lama To Deliver Major Address On 90th Birthday As China Tracks Succession Moves
The 14th Dalai Lama will address a major three-day gathering of Buddhist religious figures this week ahead of his 90th birthday.
In a blow to Milei, a US judge orders Argentina to turn over its majority stake in state oil company
BUENOS AIRES, Argentina (AP) — The fate of Argentina’s state-run oil company was thrown into doubt Monday as a U.S. judge ordered the cash-strapped country to give up its 51% controlling stake in YPF in partial compensation for seizing the shares of former investors during its 2012 nationalization of the energy group.
How to Hack a $1.3T Market - Ad
Forget concrete. The new foundation for real estate success is digital, and Pacaso leads the way. Their tech unlocks a $1.3T real estate market. They've already earned $110M+ in gross profits in their operating history and reserved the Nasdaq ticker PCSO.
Steve Jobs Took Secrecy To Fight Club Levels For This Critical Mission At Apple — 'People Thought They Knew…But Nobody Knew'
Apple's original iPhone team, under Steve Jobs, operated with intense secrecy, likening their work to "Fight Club," with no one outside the core group knowing the device's design until its 2007 debut.
Trump says he’s terminating trade talks with Canada over tax on technology firms
WASHINGTON (AP) — President Donald Trump said he’s immediately suspending over its plans to continue with its tax on technology firms, which he called “a direct and blatant attack on our country.”
Is Elon's Empire Crumbling? - Ad
Jeff Brown - the legend who called Tesla and Nvidia early - says Elon is about to launch a $25T AI revolution. This isn't another chatbot. It's real-world AI that could 14X the impact of ChatGPT. But after July 23rd, it may be too late.
OpenAI Says Tokens Are Not Equity, No Partnership With Robinhood: Musk Says AI Company's Equity 'Is Fake'
OpenAI says the "OpenAI tokens" offered by Robinhood are not OpenAI equity and clarified that it has no partnership or involvement with Robinhood.
Hong Kong's security net extends beyond arrests as small businesses pressured
HONG KONG (AP) — It’s been years since all but silenced pro-democracy activism in Hong Kong. But a crackdown on dissent in the semiautonomous Chinese city is still expanding, hitting restaurants, bookstores and other small businesses.
No.1 Opportunity for 2025 [Take Action Now!] - Ad
Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.
Nike soars on a production shift away from China, but it warns of a $1 billion tariff hit
Nike's shares jumped at the opening bell Friday after the company said it's shifting some production away from China. But it also warned that tariffs imposed by the Trump administration will cost it about $1 billion before it makes internal changes, which include “surgical” price increases in the U.S. starting this fall.
Ex-Juventus president Andrea Agnelli seeks plea bargain deal in false accounting case
ROME (AP) — Former Juventus president has requested a plea bargain deal that would give him a 20-month sentence in a false accounting trial that contributed to his downfall at the record 36-time Serie A champion.
A Historic Gold Announcement Is About to Rock Wall Street - Ad
The greatest investor of all time is about to validate what Garrett Goggin has been saying for months: Gold is entering a once-in-a-generation mania. Front-running Buffett has never been more urgent - and four tiny miners could be your ticket to 100X gains.
BigBear.Ai, Nike, Core Scientific, Cyngn, And Amazon: Why These 5 Stocks Are On Investors' Radars Today
The S&P 500 index soared to record highs on Thursday, marking a significant recovery from the steep selloff experienced just a few months ago.
Trump Has 'Already Won' By Dodging Accountability In Fed Showdown, Says Apollo's Jim Zelter
According to Jim Zelter of Apollo Global Management, President Donald Trump has already set the stage for passing the blame.
The Missing Ingredient for Big Tech's $3T Recipe? - Ad
Big Tech doesn't build everything; they buy what's next. And only Emteq's tech offers real behavior insights for smart glasses, key to unlocking the $3T XR market. Their patented sensors track live facial muscle movements. With health-focused smart glasses in demand, only Emteq has this tech.
Michael Novogratz's Galaxy And Invesco File To Launch Solana ETF: What You Should Know About QSOL
Asset management giant Invesco filed for a cryptocurrency exchange-traded fund focused on Solana (CRYPTO: SOL) on Wednesday, expanding its offerings beyond Bitcoin (CRYPTO: BTC).
New JPMorgan ETF Offers A Different Route To Income Investing
JMTG is the company's newest mutual fund conversion, offering investors specific exposure to the mortgage-backed securities.
Back This Medical AI Tech - Ad
You don't often find healthcare tech company valued at $4M. HeartSciences is an exception. With $75M invested, including R&D, clinical trials, and product development, their patented AI software is approaching FDA submission, a potential major inflection point.
As Trump Weighs Options On Iran — Dow Futures Slip, Defense Stocks Tick Up In After-Hours Session
As tensions continue to flare in the Middle East, U.S. Stock futures inch lower on Wednesday evening, compounded by the Fed's decision to hold rates steady, while warning of lower economic growth and persistent inflation.
Melinda French Gates Reveals The No. 1 Skill Women Need To Reach The C-Suite: 'You Learn To Fail And That Failing Is...'
Billionaire philanthropist Melinda French Gates has suggested that playing sports could be a major factor in the success of women in the C-suite.
The Tesla Shock Nobody Sees Coming - Ad
While headlines scream "Tesla is doomed"...Jeff Brown has uncovered a revolutionary AI breakthrough buried inside Tesla's labs. One that is helping AI escape from our computer screens and manifest itself here in the real world all while creating a 25,000% growth market explosion starting as early as July 23rd.
'How to Train Your Dragon' soars in box office debut with $83 million, beating 'Lilo and Stitch'
LOS ANGELES (AP) — took flight at the box office this weekend, proving that some .
Goldman Just Launched Two New Bond ETFs; Here's Why Investors Should Pay Attention
Goldman Sachs Asset Management debuts two new actively managed fixed income ETFs in response to rising demand for active strategies in a volatile rate landscape.
The Unlikely Duo Rethinking Wearable Technology - Ad
Why did a surgeon and Snap exec team up? They saw the missing ingredient in the $84T wearables market: behavior. So they built Emteq and invented smart glasses sensors to track real-time expressions, unlocking insights into why we do things. With a $15M term sheet already secured, Emteq is what Big Tech's missing.
Russian Spy Chief And CIA Director Ratcliffe Agree To 'Call Any Time' Amid Tensions: Report
Russian spy chief Sergei Naryshkin and the Director of the Central Intelligence Agency (CIA), John Ratcliffe, have reportedly agreed to have direct communication at any time.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.